Gastroenterology
Latest News
Doctors Caution Over Weight Loss Drug Link to Nurse’s Death
While tirzepatide can be associated with uncommon problems such as acute pancreatitis, “one can develop acute...
Feature
What Matters Most for Young Patients With CRC: Survey Highlights Top Concerns
Cancer is ‘impacting younger people who are in important developmental stages of their lives.’
From the Journals
Many Patients With Cancer Visit EDs Before Diagnosis
Factors associated with an increased likelihood of an ED visit ahead of diagnosis included having certain cancers, living in rural areas, and...
Latest News
Scurvy: A Diagnosis Still Relevant Today
Scurvy can cause mucosal and gastric hemorrhages, and may be linked to poor diet or bariatric surgery.
Conference Coverage
Angiotensin Receptor Blockers May Lead to Worse Outcomes in Celiac Disease
The association may be related to the similar pathophysiology between ARB-associated enteropathy and celiac disease.
Sponsored Supplement
Three Clinical Studies Demonstrating Safety and Efficacy of Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) in Adults
From the Journals
Plasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With Cancer
The findings support possible small net protective roles of omega-3 and omega-6 PUFAs in the development of new cancer incidence, the researchers...
From the Journals
GLP-1 RAs Safe in the Perioperative Period: New Guidance
GLP-1 RAs are known to delay gastric emptying, raising concerns about regurgitation, aspiration, and airway compromise during anesthesia.
Conference Coverage
Shorter H pylori Treatment With Vonoprazan Shows Better Results
The triple therapy regimen with vonoprazan was generally better tolerated than the 14-day omeprazole-based regimen.
Latest News
No Link Between PPI Use and Risk for Cardiovascular Events
Patients with gastroesophageal reflux disease do experience a slight increase in cardiovascular events with PPI use, the researchers noted.
Conference Coverage
AI-Assisted Colonoscopy Linked to Higher Rate of Benign Lesion Removal
The findings indicate that full adoption of AIAC could result in about 600,000 more colonoscopies in which only benign, nonadenomatous lesions are...
Conference Coverage
Guselkumab Efficacy in Crohn’s Disease Unaffected by Prior Biologic Use
Almost all patients in the biologic-inadequate response group had previously received at least one anti–tumor necrosis factor agent, and around 15...